Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa
Béatrice Bocquet, … , Muriel Perron, Vasiliki Kalatzis
Béatrice Bocquet, … , Muriel Perron, Vasiliki Kalatzis
Published September 28, 2023
Citation Information: JCI Insight. 2023;8(21):e169426. https://doi.org/10.1172/jci.insight.169426.
View: Text | PDF
Research Article Genetics Ophthalmology

TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa

  • Text
  • PDF
Abstract

Retinitis pigmentosa (RP) is the most common inherited retinal disease (IRD) and is characterized by photoreceptor degeneration and progressive vision loss. We report 4 patients presenting with RP from 3 unrelated families with variants in TBC1D32, which to date has never been associated with an IRD. To validate TBC1D32 as a putative RP causative gene, we combined Xenopus in vivo approaches and human induced pluripotent stem cell–derived (iPSC-derived) retinal models. Our data showed that TBC1D32 was expressed during retinal development and that it played an important role in retinal pigment epithelium (RPE) differentiation. Furthermore, we identified a role for TBC1D32 in ciliogenesis of the RPE. We demonstrated elongated ciliary defects that resulted in disrupted apical tight junctions, loss of functionality (delayed retinoid cycling and altered secretion balance), and the onset of an epithelial-mesenchymal transition–like phenotype. Last, our results suggested photoreceptor differentiation defects, including connecting cilium anomalies, that resulted in impaired trafficking to the outer segment in cones and rods in TBC1D32 iPSC-derived retinal organoids. Overall, our data highlight a critical role for TBC1D32 in the retina and demonstrate that TBC1D32 mutations lead to RP. We thus identify TBC1D32 as an IRD-causative gene.

Authors

Béatrice Bocquet, Caroline Borday, Nejla Erkilic, Daria Mamaeva, Alicia Donval, Christel Masson, Karine Parain, Karolina Kaminska, Mathieu Quinodoz, Irene Perea-Romero, Gema Garcia-Garcia, Carla Jimenez-Medina, Hassan Boukhaddaoui, Arthur Coget, Nicolas Leboucq, Giacomo Calzetti, Stefano Gandolfi, Antonio Percesepe, Valeria Barili, Vera Uliana, Marco Delsante, Francesca Bozzetti, Hendrik P.N. Scholl, Marta Corton, Carmen Ayuso, Jose M. Millan, Carlo Rivolta, Isabelle Meunier, Muriel Perron, Vasiliki Kalatzis

×

Figure 4

Xenopus RPE and photoreceptor marker expression following tbc1d32 knockdown.

Options: View larger image (or click on image) Download as PowerPoint

Xenopus RPE and photoreceptor marker expression following tbc1d32 knock...
(A) Diagram of the experimental design. Whole mount (B) or retinal sections (C) following in situ hybridization against mitf or ihh, respectively, on embryos injected with control Mo or tbc1d32 Mo1. Scatterplots represent the quantification of the integrated density of the staining per eye relative to control Mo; each dot corresponds to 1 eye or 1 section, respectively. (D) Rho and SM opsin immunolabeling on retinal sections of embryos injected with control Mo or embryos injected with 2 doses of tbc1d32 Mo1 (10 or 15 ng). Lower panels, enlargement of the areas indicated by white dashed boxes in the upper panels. The bar plot represents the proportion of eyes with altered staining of Rho and SM opsin for each condition. The number of eyes analyzed per condition is indicated in each bar. Rho, rhodopsin; SM opsin, short and middle wavelength cone opsin. (E) Upper panels, whole-mount in situ hybridization against rhodopsin in embryos injected with control Mo or tbc1d32 Mo1. Lower panels, transverse retinal sections of control and morphant embryos. The scatterplots represent the quantification of the integrated density of rhodopsin staining relative to control Mo; each dot corresponds to 1 eye (left) or 1 section (right). For all scatterplots, data are represented as mean ± SEM. **P < 0.01; ***P < 0.001; ****P < 0.0001; Fisher’s exact test (D); 2-tailed Mann-Whitney test (B, C, and E). Scale bars = 400 μm for whole-mount embryos and 40 μm for sections.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts